296 related articles for article (PubMed ID: 36903470)
21. Intestinal mucus is capable of stabilizing supersaturation of poorly water-soluble drugs.
Yeap YY; Lock J; Lerkvikarn S; Semin T; Nguyen N; Carrier RL
J Control Release; 2019 Feb; 296():107-113. PubMed ID: 30527813
[TBL] [Abstract][Full Text] [Related]
22. Revisiting Supersaturation of a Biopharmaceutical Classification System IIB Drug: Evaluation via a Multi-Cup Dissolution Approach and Molecular Dynamic Simulation.
Gan Y; Xu Y; Zhang X; Hu H; Xiao W; Yu Z; Sun T; Zhang J; Wen C; Zheng S
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836805
[TBL] [Abstract][Full Text] [Related]
23. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?
Brouwers J; Brewster ME; Augustijns P
J Pharm Sci; 2009 Aug; 98(8):2549-72. PubMed ID: 19373886
[TBL] [Abstract][Full Text] [Related]
24. Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug.
Pathak SM; Ruff A; Kostewicz ES; Patel N; Turner DB; Jamei M
Mol Pharm; 2017 Dec; 14(12):4305-4320. PubMed ID: 28771009
[TBL] [Abstract][Full Text] [Related]
25. Assessment of Biopharmaceutical Performance of Supersaturating Formulations of Carbamazepine in Rats Using Physiologically Based Pharmacokinetic Modeling.
Thakore SD; Thakur PS; Shete G; Gangwal R; Narang AS; Sangamwar AT; Bansal AK
AAPS PharmSciTech; 2019 Apr; 20(5):179. PubMed ID: 31041552
[TBL] [Abstract][Full Text] [Related]
26. In vitro models for the prediction of in vivo performance of oral dosage forms.
Kostewicz ES; Abrahamsson B; Brewster M; Brouwers J; Butler J; Carlert S; Dickinson PA; Dressman J; Holm R; Klein S; Mann J; McAllister M; Minekus M; Muenster U; Müllertz A; Verwei M; Vertzoni M; Weitschies W; Augustijns P
Eur J Pharm Sci; 2014 Jun; 57():342-66. PubMed ID: 23988843
[TBL] [Abstract][Full Text] [Related]
27. Haste Makes Waste: The Interplay Between Dissolution and Precipitation of Supersaturating Formulations.
Sun DD; Lee PI
AAPS J; 2015 Nov; 17(6):1317-26. PubMed ID: 26338234
[TBL] [Abstract][Full Text] [Related]
28. Quantitative analysis of the effect of supersaturation on in vivo drug absorption.
Takano R; Takata N; Saito R; Furumoto K; Higo S; Hayashi Y; Machida M; Aso Y; Yamashita S
Mol Pharm; 2010 Oct; 7(5):1431-40. PubMed ID: 20704264
[TBL] [Abstract][Full Text] [Related]
29. Aggregated Solution Morphology of Poly(acrylic acid)-Poly(styrene) Block Copolymers Improves Drug Supersaturation Maintenance and Caco-2 Cell Membrane Permeation.
Purchel AA; Boyle WS; Reineke TM
Mol Pharm; 2019 Nov; 16(11):4423-4435. PubMed ID: 31633362
[TBL] [Abstract][Full Text] [Related]
30. Integration of Precipitation Kinetics From an In Vitro, Multicompartment Transfer System and Mechanistic Oral Absorption Modeling for Pharmacokinetic Prediction of Weakly Basic Drugs.
Patel S; Zhu W; Xia B; Sharma N; Hermans A; Ehrick JD; Kesisoglou F; Pennington J
J Pharm Sci; 2019 Jan; 108(1):574-583. PubMed ID: 30395833
[TBL] [Abstract][Full Text] [Related]
31. Development of a Unified Dissolution and Precipitation Model and Its Use for the Prediction of Oral Drug Absorption.
Jakubiak P; Wagner B; Grimm HP; Petrig-Schaffland J; Schuler F; Alvarez-Sánchez R
Mol Pharm; 2016 Feb; 13(2):586-98. PubMed ID: 26674605
[TBL] [Abstract][Full Text] [Related]
32. Characterization of supersaturatable formulations for improved absorption of poorly soluble drugs.
Gao P; Shi Y
AAPS J; 2012 Dec; 14(4):703-13. PubMed ID: 22798021
[TBL] [Abstract][Full Text] [Related]
33. Non-Sink Dissolution Conditions for Predicting Product Quality and In Vivo Performance of Supersaturating Drug Delivery Systems.
Sun DD; Wen H; Taylor LS
J Pharm Sci; 2016 Sep; 105(9):2477-2488. PubMed ID: 27174227
[TBL] [Abstract][Full Text] [Related]
34. Investigation of supersaturation and in vitro permeation of the poorly water soluble drug ezetimibe.
Alhayali A; Selo MA; Ehrhardt C; Velaga S
Eur J Pharm Sci; 2018 May; 117():147-153. PubMed ID: 29408604
[TBL] [Abstract][Full Text] [Related]
35. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
[TBL] [Abstract][Full Text] [Related]
36. Polymer/lipid interplay in altering in vitro supersaturation and plasma concentration of a model poorly soluble drug.
Peng R; Huang J; He L; Zhao L; Wang C; Wei W; Xia T; Mao Y; Wen Y; Wang L; Yang J
Eur J Pharm Sci; 2020 Apr; 146():105262. PubMed ID: 32060005
[TBL] [Abstract][Full Text] [Related]
37. Studying the Propensity of Compounds to Supersaturate: A Practical and Broadly Applicable Approach.
Palmelund H; Madsen CM; Plum J; Müllertz A; Rades T
J Pharm Sci; 2016 Oct; 105(10):3021-3029. PubMed ID: 27488902
[TBL] [Abstract][Full Text] [Related]
38. Investigation of novel supersaturating drug delivery systems of chlorthalidone: The use of polymer-surfactant complex as an effective carrier in solid dispersions.
França MT; Nicolay Pereira R; Klüppel Riekes M; Munari Oliveira Pinto J; Stulzer HK
Eur J Pharm Sci; 2018 Jan; 111():142-152. PubMed ID: 28964949
[TBL] [Abstract][Full Text] [Related]
39. Gastrointestinal dissolution, supersaturation and precipitation of the weak base indinavir in healthy volunteers.
Rubbens J; Brouwers J; Tack J; Augustijns P
Eur J Pharm Biopharm; 2016 Dec; 109():122-129. PubMed ID: 27693678
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
Fei Y; Kostewicz ES; Sheu MT; Dressman JB
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
